Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 8:43 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 313–336 of 4,436 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Reports Clear all

Conditions: HIV Infections, Opioid Use, Trauma, Psychological
Interventions: Expressive Writing, Contingency Management; Behavioral
Lead sponsor: Drexel University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 219 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Ductal Breast Carcinoma in Situ, Breast Cancer, Stage I, Breast Cancer, Stage II, Breast Cancer, Stage III
Interventions: omega-3 fatty acid, placebo, Questionnaire administration; Dietary Supplement · Other · Behavioral
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 45 Years to 65 Years · Female only
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: CBD, Pain, Chronic, Anxiety, Insomnia, Opioid Use
Interventions: CBD; Drug
Lead sponsor: Advanced Pain and Rehab Specialists; Other
Eligibility: 18 Years to 90 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Hermitage, Pennsylvania

Conditions: Physical Activity
Interventions: Out of School Time Coach (OST-Coach); Behavioral
Lead sponsor: Kansas State University; Other
Eligibility: 5 Years to 11 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Manhattan, Kansas

Conditions: Erectile Dysfunction, Sexual Dysfunction
Interventions: Placebo, Dapoxetine, PDE5I (phosphodiesterase-5 inhibitor); Drug
Lead sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 495 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 19
States / cities: Decatur, Alabama • Huntsville, Alabama • Englewood, Colorado + 16 more

Conditions: Heart Failure, Congestive
Interventions: BioZ Dx; Device
Lead sponsor: CardioDynamics; Industry
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 3
States / cities: Sacramento, California • San Diego, California

Conditions: Smoking Cessation, Smoking, Nicotine Dependence
Interventions: Varenicline, Nicotine lozenge, Nicotine Patch; Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 99 Years
Enrollment: 1,086 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 2
States / cities: Madison, Wisconsin • Milwaukee, Wisconsin

Conditions: Alcohol Use, Unspecified
Interventions: Deviance Regulation Theory; Behavioral
Lead sponsor: University of Central Florida; Other
Eligibility: 18 Years to 21 Years
Enrollment: 157 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Metastatic Castration-resistant Prostate Cancer
Interventions: NKTR-214 (Cohort A), Nivolumab (Cohort A, B and C), Stereotactic body radiation therapy (SBRT) (Cohort B), CDX-301 (Cohort B and C), Poly-ICLC (Cohort B), INO-5151 (Cohort C), Cellectra 2000; Drug · Radiation · Device
Lead sponsor: Parker Institute for Cancer Immunotherapy; Other
Eligibility: 18 Years and older · Male only
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 6
States / cities: Los Angeles, California • San Francisco, California • New York, New York + 2 more

Conditions: Metastatic Cancer
Interventions: Metastatic Cancer; Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 425 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Obesity
Interventions: Food Craving app, Sleep Coach app; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 55 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Pancreatic Solid Lesions
Interventions: Artificial Intelligence software ROSE; Other
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 100 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Heart Arrest
Interventions: dispatcher-assisted CPR with compressions & ventilations, dispatcher-assisted CPR instructions with compressions only; Other
Lead sponsor: Public Health - Seattle and King County; Government
Eligibility: 9 Years and older
Enrollment: 5,494 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2012
U.S. locations: 2
States / cities: Olympia, Washington • Seattle, Washington

Conditions: Cancer
Interventions: Family History Information, ORAGENE, Blood, Skin Biopsy; Other · Genetic
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: Not listed
Enrollment: 1,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2029
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Lung Cancer, Pulmonary Nodule, Solitary
Interventions: Optellum Virtual Nodule Clinic; Device
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 35 Years to 89 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 3
States / cities: Philadelphia, Pennsylvania

Conditions: Heroin Dependence
Interventions: Virtual Reality Cue Exposure Therapy, Relapse Prevention Drug Education; Behavioral
Lead sponsor: University of Houston; Other
Eligibility: 18 Years to 64 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Houston, Texas

Conditions: PARKINSON DISEASE (Disorder)
Interventions: Prebiotic fiber bar; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Stanford, California

Conditions: Type 2 Diabetes
Interventions: Continuous Glucose Monitor, Patient Reported Outcome Questionnaires; Device · Other
Lead sponsor: Stanford University; Other
Eligibility: 4 Years to 19 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Stress, Physiological, Stress, Emotional, Insomnia
Interventions: Mindfulness Meditation, Cyclic Sighing Breathing, Box Breathing, Cyclic Hyperventilation with Retention; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 2
States / cities: Palo Alto, California • Stanford, California

Conditions: Antimicrobial Stewardship, Acute Bronchitis, Upper Respiratory Infection
Interventions: Antibiotic Stewardship; Behavioral
Lead sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; Other
Eligibility: 21 Years and older
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Pediatric Obesity, Binge-Eating Disorder
Interventions: Observational (not including MRI scanning), Observational (including MRI scanning); Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 9 Years to 12 Years
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2028
U.S. locations: 2
States / cities: Pittsburgh, Pennsylvania • Providence, Rhode Island

Conditions: Premenstrual Dysphoric Disorder
Interventions: Sertraline, Placebo; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 48 Years · Female only
Enrollment: 252 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 3
States / cities: New Haven, Connecticut • New York, New York • Richmond, Virginia

Conditions: Dental Fear
Interventions: Dental FearLess app, In-Chair Treatment Protocol; Behavioral
Lead sponsor: New York University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 2
States / cities: Brooklyn, New York • New York, New York

Conditions: Substance Abuse, Depression, Anxiety Disorder
Interventions: Mindfulness Based Relapse Prevention (MBRP), Twelve-Step Facilitation Intervention (TSF); Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 75 Years
Enrollment: 204 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 2
States / cities: Tuscaloosa, Alabama • Charleston, South Carolina

Search by objective public record fields.

Trauma Intervention to Optimize PrEP Among Women Who Inject Drugs

Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors

The Study of Hemp Oil CBD for Evaluation of Efficacy and Safety in Treatment of Pain, Anxiety and Insomnia Management

Data Coaching Process to Address Staff Physical Activity Promoting Behavior and Child Physical Activity

Concomitant Use of PriLigy in Men Treated for Erectile Dysfunction

PREVENT-HF: Prevention of Heart Failure Events With Impedance Cardiography Testing

A Comparative Effectiveness & Long Term Health Study in Wisconsin Smokers

Longitudinal Use of Protective Behavioral Strategies

Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel Combinations

A Study of the ApricityCare Program for Early Detection and Management of Treatment-Related Adverse Events in Patients With Cancer

The Sleep and Weight Study

Artificial Intelligence (AI) Cytopathology Trial

Dispatcher-Assisted Resuscitation Trial (DART)

Discovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of Cancer

Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES

University of Houston Drug Abuse Research Development Program II

Stanford University Neurofiber Study

Use of Continuous Glucose Monitors in Publicly-Insured Youth With Type 2 Diabetes - A Pilot and Feasibility Study

Psychophysiological Effects of Controlled Respiration and Mindfulness

Using Behavioral Science to Reduce Inappropriate Antibiotic Use in Acute Care Settings

Project THINK: Trajectories of Health, Ingestive Behaviors, and Neurocognition in Kids

Evaluating the Effectiveness of Sertraline in Treating Women With Premenstrual Dysphoric Disorder

Dissemination of a Brief Dental Fear Intervention

Mindfulness-Based Recovery in Veterans